Feb 26, 2024
GE HealthCare and Biofourmis Collaborate to Extend Patient Monitoring Outside the Hospital with Virtual Care-at-Home Solutions
Feb 15, 2024
Biofourmis and WellSpan Health Collaborate to Deliver High-Quality Hospital-Level Acute and Post-Discharge Care to Patients at Home
Feb 13, 2024
Biofourmis Secures Four New Agreements with Top-20 Pharma on Strength of Platform for Digital Clinical Trials and Digital Biomarkers
Dec 03, 2020
Biofourmis Announces National Rollout of the Biovitals® Hospital@Home(TM) Platform to Help Deliver Hospital-Level Care in the Home Aligned with New CMS Program
Jul 21, 2020
Chugai and Biofourmis Partner to Develop an Objective Assessment of Pain Using Digital Technology
Apr 16, 2020
Digital Therapeutics Leader Biofourmis Expands into Oncology Market with Strategic Acquisition of Gaido Health
Jan 30, 2020
Biofourmis Partners with ImagineMIC to Pioneer Collaborative Remote Patient Monitoring Model
Jan 27, 2020
Biofourmis Names Pharma and Tech Veterans as COO and CTO
Nov 18, 2019
Biofourmis Announces Acquisition of Biovotion AG, Completing Biovitals® Platform to Deliver Precise Interventions at the Right Time to Manage Patients with Complex Chronic Conditions
Oct 03, 2019
Biofourmis' Biovitals(TM) Analytics Engine Receives FDA Clearance for Ambulatory Physiologic Monitoring
May 21, 2019
Biofourmis Closes $35 Million Series B Financing Round to Advance Artificial Intelligence-Powered Digital Therapeutics Platform
Apr 30, 2019
Biofourmis' RhythmAnalytics(TM) Platform Receives FDA Clearance for AI-Based Automated Interpretation of Cardiac Arrhythmias
Mar 13, 2019
BiovitalsHF(TM), a Prescription Software Uses Data Science to Augment Guideline-directed Use of Heart Failure Therapies